Literature DB >> 20863782

GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra.

Hernán Cortés1, Francisco Paz, David Erlij, Jorge Aceves, Benjamín Florán.   

Abstract

GABA(B) receptors decrease the release of GABA from the striatal terminals within the pars reticulata of the substantia nigra by opposing the increase in the release caused by dopamine D₁ receptors. The dopamine D₁ receptors also increase the release of glutamate from subthalamic terminals in the pars reticulata. Because GABA(B) receptors decrease the glutamate release from these terminals, we have explored if the effect of GABA(B) receptors also opposed the effect of the dopamine D₁ receptors. The effect of baclofen, a selective GABA(B)-receptor agonist, was tested on the release of [³H]glutamate caused by highly (40 mM) concentrated K(+) solutions in slices of the pars reticulata. Baclofen decreased (the concentration causing 50% inhibition, IC₅₀, was 8.15 μM) the increase in the release of the [³H]glutamate caused by the dopamine D₁ receptors and it also decreased (IC₅₀ was 0.51 μM) this release in the absence of the activation of the dopamine D₁ receptors. The GABA(B) receptors appear then to inhibit glutamate release in two ways; one dependent on the activation of the dopamine D₁ receptors and the other independent of such activation. The protein kinase A-inhibitor H89 blocked the increase in the release of the [³H]glutamate caused by the dopamine D₁ receptors, though it did not block the dopamine D₁ receptor-independent baclofen inhibition of the release. This finding indicates that this inhibition was not via the protein kinase A signal-transduction pathway. N-ethylmaleimide, an alkylating agent that inactivates pertussis toxin-sensitive Gi proteins, eliminated both the dopamine D₁ receptor-dependent and -independent baclofen inhibition, showing that both were mediated by these proteins. The injection of baclofen into the pars reticulata of unanesthetized rats caused contralateral rotation, suggesting a reduced glutamate release from the subthalamic terminals, thereby stopping the inhibition of the premotor thalamic nuclei, causing locomotion. Our data suggest that GABA(B) receptors restrain the excitatory input from the subthalamic nucleus and stimulate motor behavior.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863782     DOI: 10.1016/j.ejphar.2010.09.024

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Endogenous content and release of [(3)H]-GABA and [(3)H]-glutamate in the spinal cord of chronically undernourished rat.

Authors:  Salvador Quiróz-González; Rodrigo Erick Escartín-Pérez; Francisco Paz-Bermudez; Bertha Segura-Alegría; Celia Reyes-Legorreta; José Carlos Guadarrama-Olmos; Benjamin Florán-Garduño; Ismael Jiménez-Estrada
Journal:  Neurochem Res       Date:  2012-09-15       Impact factor: 3.996

2.  Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain.

Authors:  S González; C Rangel-Barajas; M Peper; R Lorenzo; E Moreno; F Ciruela; J Borycz; J Ortiz; C Lluís; R Franco; P J McCormick; N D Volkow; M Rubinstein; B Floran; S Ferré
Journal:  Mol Psychiatry       Date:  2011-08-16       Impact factor: 15.992

3.  Natural Product Isoliquiritigenin Activates GABAB Receptors to Decrease Voltage-Gate Ca2+ Channels and Glutamate Release in Rat Cerebrocortical Nerve Terminals.

Authors:  Tzu-Yu Lin; Cheng-Wei Lu; Pei-Wen Hsieh; Kuan-Ming Chiu; Ming-Yi Lee; Su-Jane Wang
Journal:  Biomolecules       Date:  2021-10-18

4.  Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction among Glutamate, Dopamine, and GABA.

Authors:  Marina Rodríguez-Sánchez; Rodrigo Erick Escartín-Pérez; Gerardo Leyva-Gómez; José Arturo Avalos-Fuentes; Francisco Javier Paz-Bermúdez; Santiago Iván Loya-López; Jorge Aceves; David Erlij; Hernán Cortés; Benjamín Florán
Journal:  Biomolecules       Date:  2019-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.